 Vanja Dukic
Concepts (209)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Moths | 7 | 2025 | 52 | 2.260 |
Why?
| | Models, Biological | 9 | 2026 | 1820 | 1.560 |
Why?
| | Population Dynamics | 6 | 2025 | 158 | 1.300 |
Why?
| | Nonlinear Dynamics | 3 | 2026 | 95 | 1.040 |
Why?
| | Mathematical Concepts | 3 | 2026 | 36 | 1.010 |
Why?
| | Epidemics | 2 | 2020 | 98 | 0.930 |
Why?
| | Models, Statistical | 7 | 2017 | 677 | 0.790 |
Why?
| | Smoking | 7 | 2012 | 1468 | 0.740 |
Why?
| | Methicillin-Resistant Staphylococcus aureus | 3 | 2014 | 248 | 0.660 |
Why?
| | Whooping Cough | 1 | 2019 | 55 | 0.610 |
Why?
| | Staphylococcal Infections | 3 | 2014 | 388 | 0.600 |
Why?
| | Public Health Surveillance | 1 | 2019 | 83 | 0.600 |
Why?
| | Self Disclosure | 2 | 2009 | 62 | 0.550 |
Why?
| | Host-Pathogen Interactions | 4 | 2025 | 371 | 0.520 |
Why?
| | Baculoviridae | 3 | 2025 | 44 | 0.500 |
Why?
| | Smallpox | 2 | 2013 | 10 | 0.460 |
Why?
| | Pregnancy Complications | 3 | 2012 | 592 | 0.430 |
Why?
| | Survival Analysis | 1 | 2017 | 1382 | 0.400 |
Why?
| | Bayes Theorem | 5 | 2014 | 433 | 0.370 |
Why?
| | Monte Carlo Method | 4 | 2020 | 155 | 0.370 |
Why?
| | Warfare | 2 | 2011 | 99 | 0.350 |
Why?
| | Community-Acquired Infections | 1 | 2013 | 174 | 0.330 |
Why?
| | Cotinine | 2 | 2009 | 79 | 0.320 |
Why?
| | Proportional Hazards Models | 2 | 2017 | 1322 | 0.310 |
Why?
| | Maternal Exposure | 3 | 2012 | 213 | 0.310 |
Why?
| | Biological Assay | 1 | 2009 | 127 | 0.280 |
Why?
| | Periodicals as Topic | 1 | 2011 | 203 | 0.280 |
Why?
| | General Surgery | 1 | 2011 | 207 | 0.280 |
Why?
| | Population Surveillance | 1 | 2011 | 483 | 0.270 |
Why?
| | Ecosystem | 2 | 2024 | 589 | 0.260 |
Why?
| | Systems Biology | 2 | 2026 | 72 | 0.250 |
Why?
| | Computer Simulation | 4 | 2026 | 1025 | 0.240 |
Why?
| | Internet | 1 | 2011 | 698 | 0.240 |
Why?
| | Geography | 2 | 2019 | 203 | 0.240 |
Why?
| | Algorithms | 4 | 2026 | 1834 | 0.240 |
Why?
| | Models, Psychological | 2 | 2011 | 296 | 0.230 |
Why?
| | Larva | 3 | 2023 | 242 | 0.220 |
Why?
| | Neoplasm Recurrence, Local | 2 | 2008 | 1137 | 0.220 |
Why?
| | Biomedical Research | 1 | 2011 | 709 | 0.210 |
Why?
| | Antipsychotic Agents | 1 | 2006 | 207 | 0.210 |
Why?
| | Selection, Genetic | 1 | 2025 | 256 | 0.200 |
Why?
| | Biometry | 1 | 2003 | 68 | 0.200 |
Why?
| | Prenatal Exposure Delayed Effects | 4 | 2012 | 674 | 0.190 |
Why?
| | Cannibalism | 1 | 2023 | 3 | 0.190 |
Why?
| | Tobacco Smoke Pollution | 3 | 2012 | 233 | 0.190 |
Why?
| | Wounds and Injuries | 1 | 2011 | 952 | 0.190 |
Why?
| | Schizophrenia | 1 | 2006 | 444 | 0.180 |
Why?
| | Animals | 10 | 2026 | 38030 | 0.180 |
Why?
| | Host-Parasite Interactions | 1 | 2023 | 112 | 0.180 |
Why?
| | Insecta | 1 | 2021 | 74 | 0.170 |
Why?
| | Basic Reproduction Number | 1 | 2020 | 6 | 0.160 |
Why?
| | Humans | 30 | 2025 | 144261 | 0.160 |
Why?
| | Entomophthorales | 1 | 2020 | 1 | 0.160 |
Why?
| | Pregnancy | 11 | 2012 | 7180 | 0.160 |
Why?
| | Public Health Informatics | 1 | 2019 | 10 | 0.160 |
Why?
| | Insect Control | 1 | 2020 | 18 | 0.160 |
Why?
| | Search Engine | 1 | 2019 | 12 | 0.150 |
Why?
| | Machine Learning | 1 | 2025 | 585 | 0.150 |
Why?
| | Weather | 1 | 2020 | 43 | 0.150 |
Why?
| | Reproducibility of Results | 3 | 2019 | 3403 | 0.150 |
Why?
| | Social Class | 2 | 2019 | 268 | 0.150 |
Why?
| | Morbidity | 1 | 2019 | 323 | 0.140 |
Why?
| | Breast Neoplasms | 2 | 2008 | 2447 | 0.140 |
Why?
| | Disease Susceptibility | 1 | 2020 | 346 | 0.140 |
Why?
| | Software | 1 | 2023 | 690 | 0.140 |
Why?
| | Communicable Diseases | 1 | 2020 | 163 | 0.130 |
Why?
| | Alphapapillomavirus | 1 | 2017 | 35 | 0.130 |
Why?
| | Models, Theoretical | 3 | 2020 | 582 | 0.130 |
Why?
| | Data Interpretation, Statistical | 2 | 2017 | 371 | 0.120 |
Why?
| | Biodiversity | 1 | 2020 | 426 | 0.120 |
Why?
| | Androgen Antagonists | 1 | 2017 | 91 | 0.120 |
Why?
| | Neoplasm Grading | 1 | 2017 | 307 | 0.120 |
Why?
| | Treatment Failure | 1 | 2017 | 363 | 0.120 |
Why?
| | Adult | 13 | 2019 | 40262 | 0.110 |
Why?
| | Uncertainty | 2 | 2013 | 144 | 0.110 |
Why?
| | Cooking | 1 | 2015 | 67 | 0.110 |
Why?
| | Climate | 1 | 2015 | 89 | 0.110 |
Why?
| | United States | 4 | 2019 | 15876 | 0.100 |
Why?
| | Epilepsy, Generalized | 1 | 2014 | 19 | 0.100 |
Why?
| | Prevalence | 3 | 2023 | 2815 | 0.100 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2014 | 70 | 0.100 |
Why?
| | Mothers | 2 | 2012 | 774 | 0.100 |
Why?
| | Papillomavirus Infections | 1 | 2017 | 345 | 0.100 |
Why?
| | Africa | 1 | 2013 | 114 | 0.100 |
Why?
| | Biological Evolution | 1 | 2017 | 488 | 0.090 |
Why?
| | Incidence | 1 | 2019 | 2870 | 0.090 |
Why?
| | Staphylococcal Skin Infections | 1 | 2013 | 41 | 0.090 |
Why?
| | Europe | 1 | 2013 | 412 | 0.090 |
Why?
| | Birth Certificates | 1 | 2012 | 12 | 0.090 |
Why?
| | Communicable Disease Control | 1 | 2013 | 86 | 0.090 |
Why?
| | Adolescent | 7 | 2019 | 22281 | 0.090 |
Why?
| | Sensitivity and Specificity | 2 | 2009 | 1983 | 0.090 |
Why?
| | Young Adult | 4 | 2019 | 13990 | 0.090 |
Why?
| | Pregnancy Outcome | 2 | 2006 | 476 | 0.090 |
Why?
| | Croatia | 1 | 2011 | 4 | 0.090 |
Why?
| | Massachusetts | 1 | 2012 | 177 | 0.090 |
Why?
| | MEDLINE | 1 | 2011 | 20 | 0.090 |
Why?
| | Paternal Behavior | 1 | 2011 | 5 | 0.080 |
Why?
| | Air Pollution | 1 | 2015 | 326 | 0.080 |
Why?
| | Computational Biology | 2 | 2026 | 680 | 0.080 |
Why?
| | Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 55 | 0.080 |
Why?
| | Maternal Behavior | 1 | 2011 | 84 | 0.080 |
Why?
| | User-Computer Interface | 1 | 2011 | 164 | 0.080 |
Why?
| | Middle Aged | 6 | 2019 | 35762 | 0.080 |
Why?
| | Prostatic Neoplasms | 1 | 2017 | 974 | 0.080 |
Why?
| | Social Behavior Disorders | 1 | 2009 | 14 | 0.070 |
Why?
| | Monoamine Oxidase | 1 | 2009 | 25 | 0.070 |
Why?
| | Female | 15 | 2014 | 77976 | 0.070 |
Why?
| | Calibration | 1 | 2009 | 151 | 0.070 |
Why?
| | Research Design | 1 | 2015 | 1129 | 0.070 |
Why?
| | Adolescent Behavior | 2 | 2011 | 500 | 0.070 |
Why?
| | Forests | 2 | 2020 | 58 | 0.070 |
Why?
| | Time | 1 | 2008 | 86 | 0.070 |
Why?
| | Research | 2 | 2015 | 428 | 0.070 |
Why?
| | Tamoxifen | 1 | 2008 | 217 | 0.070 |
Why?
| | Databases, Factual | 2 | 2011 | 1484 | 0.070 |
Why?
| | Self Report | 1 | 2012 | 863 | 0.060 |
Why?
| | Antineoplastic Agents, Hormonal | 1 | 2008 | 194 | 0.060 |
Why?
| | Infant | 2 | 2019 | 10022 | 0.060 |
Why?
| | Risperidone | 1 | 2006 | 29 | 0.060 |
Why?
| | Bioterrorism | 1 | 2006 | 31 | 0.060 |
Why?
| | Self-Assessment | 1 | 2007 | 74 | 0.060 |
Why?
| | Haloperidol | 1 | 2006 | 33 | 0.060 |
Why?
| | Markov Chains | 1 | 2006 | 126 | 0.060 |
Why?
| | Public Health Practice | 1 | 2006 | 63 | 0.060 |
Why?
| | Smoking Prevention | 1 | 2007 | 166 | 0.060 |
Why?
| | Treatment Outcome | 3 | 2017 | 11643 | 0.060 |
Why?
| | Aged, 80 and over | 2 | 2017 | 8243 | 0.060 |
Why?
| | Fetal Development | 1 | 2009 | 299 | 0.060 |
Why?
| | Lymph Nodes | 1 | 2008 | 502 | 0.060 |
Why?
| | Benzodiazepines | 1 | 2006 | 165 | 0.060 |
Why?
| | Time Factors | 2 | 2014 | 7155 | 0.060 |
Why?
| | Adrenergic beta-Agonists | 1 | 2005 | 91 | 0.060 |
Why?
| | Prenatal Care | 1 | 2007 | 306 | 0.050 |
Why?
| | Child, Preschool | 1 | 2019 | 11774 | 0.050 |
Why?
| | Reproductive Techniques, Assisted | 1 | 2004 | 43 | 0.050 |
Why?
| | Disease Transmission, Infectious | 2 | 2020 | 69 | 0.050 |
Why?
| | Infertility | 1 | 2004 | 55 | 0.050 |
Why?
| | False Positive Reactions | 1 | 2003 | 121 | 0.050 |
Why?
| | Pregnancy, Ectopic | 1 | 2003 | 53 | 0.050 |
Why?
| | Cohort Studies | 5 | 2014 | 5935 | 0.050 |
Why?
| | Aged | 4 | 2017 | 25850 | 0.050 |
Why?
| | Spodoptera | 1 | 2023 | 40 | 0.050 |
Why?
| | Hospitalization | 2 | 2011 | 2424 | 0.050 |
Why?
| | Meta-Analysis as Topic | 1 | 2003 | 172 | 0.050 |
Why?
| | Child Welfare | 1 | 2004 | 231 | 0.050 |
Why?
| | ROC Curve | 1 | 2003 | 612 | 0.040 |
Why?
| | Case-Control Studies | 1 | 2009 | 3592 | 0.040 |
Why?
| | Child | 2 | 2019 | 22537 | 0.040 |
Why?
| | Stochastic Processes | 1 | 2020 | 71 | 0.040 |
Why?
| | Population Density | 1 | 2020 | 101 | 0.040 |
Why?
| | Prospective Studies | 2 | 2014 | 7970 | 0.040 |
Why?
| | Male | 7 | 2017 | 72035 | 0.040 |
Why?
| | Biomarkers | 2 | 2009 | 4254 | 0.040 |
Why?
| | Decision Making | 1 | 2006 | 974 | 0.040 |
Why?
| | Surveys and Questionnaires | 2 | 2012 | 6021 | 0.030 |
Why?
| | North America | 1 | 2017 | 310 | 0.030 |
Why?
| | Fetal Monitoring | 1 | 1996 | 20 | 0.030 |
Why?
| | Ultrasonography, Doppler, Color | 1 | 1996 | 37 | 0.030 |
Why?
| | Plant Leaves | 1 | 2017 | 137 | 0.030 |
Why?
| | Labor, Obstetric | 1 | 1996 | 66 | 0.030 |
Why?
| | Ghana | 1 | 2015 | 42 | 0.030 |
Why?
| | Household Articles | 1 | 2015 | 28 | 0.030 |
Why?
| | Birth Weight | 2 | 2009 | 522 | 0.030 |
Why?
| | Recurrence | 1 | 2017 | 1134 | 0.030 |
Why?
| | Asthma | 1 | 2005 | 1767 | 0.020 |
Why?
| | Equipment Design | 1 | 2015 | 530 | 0.020 |
Why?
| | Air Pollution, Indoor | 1 | 2015 | 181 | 0.020 |
Why?
| | Abdominal Injuries | 1 | 1994 | 127 | 0.020 |
Why?
| | Boston | 1 | 2012 | 92 | 0.020 |
Why?
| | Inflammation Mediators | 1 | 2014 | 508 | 0.020 |
Why?
| | Disease Outbreaks | 1 | 2014 | 422 | 0.020 |
Why?
| | Cluster Analysis | 1 | 2012 | 519 | 0.020 |
Why?
| | Social Environment | 1 | 2011 | 254 | 0.020 |
Why?
| | Body Size | 1 | 2009 | 95 | 0.020 |
Why?
| | Sex Distribution | 1 | 2009 | 380 | 0.020 |
Why?
| | Lymphatic Metastasis | 1 | 2008 | 333 | 0.020 |
Why?
| | Chemotherapy, Adjuvant | 1 | 2008 | 419 | 0.020 |
Why?
| | Environment | 1 | 2009 | 305 | 0.020 |
Why?
| | Multivariate Analysis | 1 | 2011 | 1533 | 0.020 |
Why?
| | Neoplasm Invasiveness | 1 | 2008 | 508 | 0.020 |
Why?
| | Smallpox Vaccine | 1 | 2006 | 23 | 0.020 |
Why?
| | Civil Defense | 1 | 2006 | 21 | 0.020 |
Why?
| | Receptors, Estrogen | 1 | 2008 | 457 | 0.010 |
Why?
| | Disaster Planning | 1 | 2006 | 100 | 0.010 |
Why?
| | Immunization | 1 | 2006 | 374 | 0.010 |
Why?
| | Health Status Indicators | 1 | 2005 | 165 | 0.010 |
Why?
| | Neoplasm Staging | 1 | 2008 | 1461 | 0.010 |
Why?
| | Endpoint Determination | 1 | 2004 | 83 | 0.010 |
Why?
| | Genotype | 1 | 2009 | 1833 | 0.010 |
Why?
| | Linear Models | 1 | 2006 | 850 | 0.010 |
Why?
| | Predictive Value of Tests | 1 | 2009 | 2111 | 0.010 |
Why?
| | Drug Prescriptions | 1 | 2005 | 280 | 0.010 |
Why?
| | Inflammation | 1 | 2014 | 2877 | 0.010 |
Why?
| | Quality of Life | 1 | 2015 | 3166 | 0.010 |
Why?
| | Randomized Controlled Trials as Topic | 1 | 2008 | 1705 | 0.010 |
Why?
| | Phenotype | 1 | 2009 | 3157 | 0.010 |
Why?
| | Genetic Predisposition to Disease | 1 | 2009 | 2359 | 0.010 |
Why?
| | Child Development | 1 | 2004 | 484 | 0.010 |
Why?
| | Follow-Up Studies | 1 | 2009 | 5389 | 0.010 |
Why?
| | Emergency Medical Services | 1 | 2005 | 696 | 0.010 |
Why?
| | Infant, Newborn | 1 | 2009 | 6424 | 0.010 |
Why?
| | Umbilical Arteries | 1 | 1996 | 52 | 0.010 |
Why?
| | Cerebral Arteries | 1 | 1996 | 58 | 0.010 |
Why?
| | Risk Factors | 1 | 2009 | 10699 | 0.010 |
Why?
| | Yugoslavia | 1 | 1994 | 4 | 0.010 |
Why?
| | Arteries | 1 | 1996 | 258 | 0.010 |
Why?
| | Regional Blood Flow | 1 | 1996 | 512 | 0.010 |
Why?
| | Aorta | 1 | 1996 | 429 | 0.010 |
Why?
|
|
Dukic's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|